Microbiotica
eDR20Effective DR: 20/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent41Agent Readiness: 41/100. Above median. Measured by StartupHub.ai. Median 41.British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines.
About
Microbiotica is a clinical-stage biopharmaceutical company specializing in the development of precision live biotherapeutic products (LBPs) with lead products in immuno-oncology and inflammatory bowel disease. The company leverages a genomics-driven microbiome platform to identify bacterial strains associated with favorable clinical outcomes, enabling the discovery and development of novel therapeutic products. They aim to deliver safe and precise microbiome medicines to benefit patients.
Key facts
At-a-glance profile data
- Website
- microbiotica.com
- Headquarters
- Cambridge, United Kingdom
- Founded
- 2016
- Employees
- 49
- Total funding
- $112M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Oct 2026 | Series C | $45M | British Business Bank |
| 7 Mar 2022 | Series B | $67M | Tencent |
Tech stack
Detected on microbiotica.com, last scanned 16 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Jetpack / WP.com Stats
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
- Cookie consent
- Cookiebot
- Video / media
- YouTube
Frequently asked
Is Microbiotica trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Microbiotica is 67 out of 100, based on site security posture and privacy practices.
How much funding has Microbiotica raised?
Microbiotica has raised a total of $112M in funding. The most recent round on record is Series C.
How many employees does Microbiotica have?
Microbiotica has approximately 49 people on record.